1336GCC: Study of Erwinaze for Treatment of Acute Myeloid Leukemia (AML)
- First Posted Date
- 2014-11-05
- Last Posted Date
- 2018-03-12
- Lead Sponsor
- Ashkan Emadi
- Target Recruit Count
- 5
- Registration Number
- NCT02283190
- Locations
- 🇺🇸
University of Maryland Greenebaum Cancer Center, Baltimore, Maryland, United States
© Copyright 2024. All Rights Reserved by MedPath